1. Active ingredients of Inula helenium L. exhibits similar anti-cancer effects as isoalantolactone in pancreatic cancer cells
   Y. Y. Yan et al, 2019, Natural Product Research CrossRef
2. Repeated-dose toxicity of common ragweed on rats
   Tivadar Kiss et al, 2017, PLoS ONE CrossRef
3. Isoalantolactone inhibits RANKL-induced osteoclast formation via multiple signaling pathways
   Jinwei Lu et al, 2020, International Immunopharmacology CrossRef
4. Ethyl acetate extract from Inula�helenium L. inhibits the proliferation of pancreatic cancer cells by regulating the STAT3/AKT pathway
   Bo Zhang et al, 2018, Mol Med Report CrossRef
5. Sesquiterpenes and their derivatives-natural anticancer compounds: An update
   Tareq Abu-Izneid et al, 2020, Pharmacological Research CrossRef
6. Alantolactone inhibits cervical cancer progression by downregulating BMI1.
   Xiaodong Sun et al, 2021, Sci Rep CrossRef
7. Stevia Genus: Phytochemistry and Biological Activities Update
   Jimena Borgo et al, 2021, Molecules CrossRef
8. Isoalantolactone Induces Cell Cycle Arrest, Apoptosis and Autophagy in Colorectal Cancer Cells.
   Junkui Li et al, 2022, Front Pharmacol CrossRef
9. Isoalantolactone suppresses gallbladder cancer progression via inhibiting the ERK signalling pathway
   Xingyu Lv et al, 2023, Pharmaceutical Biology CrossRef
10. Isoalantolactone Suppresses Gallbladder Cancer Progression Via Inhibiting ERK Signaling Pathway
    Xingyu Lv et al, 2022, SSRN Journal CrossRef
11. Regulation of Hippo–YAP signaling axis by Isoalantolactone suppresses tumor progression in cholangiocarcinoma
    Cho-Long Kim et al, 2024, Translational Oncology CrossRef
12. Induction of Apoptosis by Isoalantolactone in Human Hepatocellular Carcinoma Hep3B Cells through Activation of the ROS-Dependent JNK Signaling Pathway.
    Min Yeong Kim et al, 2021, Pharmaceutics CrossRef
13. Isoalantolactone: a review on its pharmacological effects
    Guang Yang et al, 2024, Front. Pharmacol. CrossRef